(Q39778207)

14 September 2017

title

Liver fibrosis in HIV-infected patients with chronic hepatitis B extensively exposed to antiretroviral therapy with anti-HBV activity (English)

1 reference

14 September 2017

0 references

anti-retroviral agent

0 references

1 reference

2

Vincent Soriano

1 reference

14 September 2017

Ivana Maida

1

1 reference

14 September 2017

Carol Castellares

3

1 reference

14 September 2017

Belén Ramos

4

1 reference

14 September 2017

Giovanni Sotgiu

5

1 reference

14 September 2017

Luz Martin-Carbonero

6

1 reference

14 September 2017

Pablo Barreiro

7

1 reference

14 September 2017

Pablo Rivas

8

1 reference

14 September 2017

Juan González-Lahoz

9

1 reference

14 September 2017

Marina Núñez

10

1 reference

14 September 2017

publication date

1 September 2006

1 reference

14 September 2017

1 reference

14 September 2017

volume

7

1 reference

14 September 2017

issue

5

1 reference

14 September 2017

page(s)

246-250

1 reference

Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men.

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1310%2FHCT0705-246

HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0705-246

Survival in patients with HIV infection and viral hepatitis B or C: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0705-246

Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0705-246

Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0705-246

Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0705-246

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0705-246

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0705-246

Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0705-246

Virological outcome of chronic hepatitis B virus infection in HIV-coinfected patients receiving anti-HBV active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0705-246

A comparison of fibrosis progression in chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0705-246

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0705-246

Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0705-246

Management of patients co-infected with hepatitis B virus and HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0705-246

21 January 2018

Identifiers

DOI

10.1310/HCT0705-246

1 reference

14 September 2017

1 reference